Effect of Magnesium Sulfate on Doppler Parameters of Fetal Umbilical and Middle Cerebral Arteries in Women with Severe Preeclampsia

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher; therefore Scientific Scholar has no control over the quality or content of this article.

Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2012/2/1/85/105269

Source of Support: Kermanshah University of Medical Sciences

Conflict of Interest: None declared.

Abstract

Objective:

To assess the effect of injecting magnesium sulfate on Doppler parameters of fetal umbilical and middle cerebral arteries (MCA) in women with severe preeclampsia.

Materials and Methods:

A total of 21 patients with severe preeclampsia admitted to Imam Reza Hospital, Kermanshah (Iran), were evaluated. Before and after administration of magnesium sulfate, Doppler ultrasound scan was carried out to measure fetal middle cerebral artery and umbilical artery blood flow. Paired t-test was used for statistical analysis.

Results:

After injection of magnesium sulfate, the mean resistivity index (RI)-umbilical, and pulsatility index (PI)-cerebral showed a statistically significant reduction (P < 0.001). The cerebroumbilical C/U ratio increased after the intervention (P < 0.001). The PI-umbilical (P = 0.1) and pre- and post-RI-cerebral (P = 0.96) did not have statistically significant changes.

Conclusions:

Infusion of magnesium sulfate significantly decreases the flow in the fetus RI-umbilical and PI-MCA, and it increases C/U ratio indices in color Doppler ultrasound.

Keywords

Doppler ultrasound

eclampsia

magnesium sulfate

preeclampsia

Show Related Articles from PubMed

INTRODUCTION

Preeclampsia is defined as increase in systolic blood pressure ≥140 mmHg or diastolic ≥90 mmHg and proteinuria ≥300 mg protein/24 hours urine and starts after 20 weeks of pregnancy. Eclampsia is the condition in which generalized seizure occur in the absence of other neurologic defects.[1]

Preeclampsia and eclampsia are among the common causes of death and disability in pregnant women and are associated with increased vascular resistance and decreased uteroplacental perfusion.[2] It is characterized by vascular contraction, lesions in the placenta and umbilical arteries, high blood pressure, proteinuria, and seizure.

This disease can cause many fetal and maternal complications. Maternal complications include acute renal failure, liver damage, intracerebral hemorrhage, pulmonary edema, and death. Fetus complications are preterm birth or intrauterine growth restriction.[3–5]

Magnesium sulfate (MgSO₄) is used for the treatment of severe preeclampsia and can help prevent serious complications.[6 7] Effect of MgSO₄ on cerebral vessels are still controversial and it is unclear whether it reduces cerebrovascular vasospasm. Studies in this area are still ongoing.[8–11] The mechanism of action may include changes in vascular permeability and reduction of edema.[6] It seems to have no adverse effects on the fetus,[12] but in response to MgSO₄ injection, fetal brain perfusion may also alter.[13]

In pregnancy, usually umbilical artery is tested by Doppler ultrasound but some recent studies also test maternal and fetal middle cerebral arteries (MCA).[14–17] In one study, the reference value of resistive index (RI) and pulsatility index (PI) have been investigated in Iranian patients.[16] The ratio of middle cerebral artery/umbilical artery (C/U ratio) can be a good indicator of fetal prognosis and fetal well-being.[16–20]

Doppler ultrasound is a useful tool for studying pathophysiological mechanisms that can affect the fetal hemodynamic status.[19 21 22] Assessing the changes in the arteries with Doppler ultrasound can show the adaptation of fetus to the situation.[17 23] An increase in umbilical artery resistance shows as a decrease in perfusion. If the situation continues, RI in the middle cerebral artery will decrease.[24] Investigating the mechanism of action of MgSO₄ on the fetus is one of the important issues in this disease.[25] The purpose of this study is to evaluate the effect of MgSO₄ in severe preeclampsia on fetal middle cerebral artery and umbilical artery using Doppler parameters.

MATERIALS AND METHODS

This is a quasi-experimental study (before-after). This study was approved by the ethics committee of Kermanshah University of Medical Sciences. Patients who needed injections of MgSO₄ were included in the study. MgSO₄ injection was administered under the supervision of a gynecologist. Prior to the intervention, Doppler ultrasound was used to evaluate the fetal middle cerebral and umbilical arteries of the patients.

Patients with severe preeclampsia who attended Imam Reza hospital, Kermanshah Iran during the period 2011-2012 were included in the study. Inclusion criteria were: Age in the range of 20-35 years, first pregnancy, gestational age above 28 weeks, systolic blood pressure ≥140 mmHg, and diastolic pressure ≥90 mmHg with the proteinuria of at least 300 mg in 24 hour urine or having urinary protein level ≥ +2, and epigastric pain. Exclusion criteria were: Any type of systemic disease (e.g., diabetes, hypertension, and autoimmune disorders), history of taking opium, smoking, twin pregnancy, and history of taking specific drugs.

During the study period 21 patients were evaluated. The goal of the study and the method were described to all patients and written consent form was taken prior to the initiation of study.

After admission of the patient in a room that had cardiopulmonary resuscitation (CPR) facilities, a radiologist recorded the color Doppler ultrasound of fetal umbilical and MCA, using a Siemens Ultrasound device (Germany), model G40, with a deep probe of 3/5-5 MHz. The mean RI and PI of MCA from the proximal part of two MCA arteries (left and right) and the C/U ratio (middle cerebral artery RI/umbilical artery RI) were evaluated. Parameters related to the umbilical artery close to the navel were evaluated.

RI = Peak systolic velocity - end diastolic velocity/peak systolic velocity

PI = Peak systolic velocity - end diastolic velocity/mean velocity

After initial assessment, a gynecologist injected the primary and maintenance dose of MgSO₄. The primary dose had 14 g of MgSO₄ of which 4 g in the form of a 20% solution was injected intravenously for at least 4 min and then immediately 10 g of MgSO₄ in the form of 50% solution was injected muscularly. Twenty minutes after intravenous injection (4 g), Doppler ultrasound was again performed to measure blood flow in fetal MCA and umbilical arteries.

Data were analyzed using SPSS version 11.5 software (SPSS Inc., Chicago, IL, USA). Kolmogrov-Smirnov test was used to prove the normal distribution of variables and all variables had normal distribution. Then the before and after intervention values were compared by Paired t-test. A level of 0.05 was considered significant.

RESULTS

In the 21 patients studied, average RI-umbilical before and after the intervention were 0.72 ( ±0.1) and 0.62 (±0.09), respectively, which showed a statistically significant decrease (P < 0.001). The before and after PI-umbilical values were 1.35 ( ±0.47) and 1.28 ( ±0.49), respectively, which was not a significant change (P = 0.1). In addition, the average before and after RI-MCA were 0.71 (±0.16) and 0.71 (±0.11), respectively, and this particular index did not show any significant change (P = 0.96). But, a statistically significant decrease (P = 0.001) was observed in the average amount of before PI-MCA 1.63 (±0.84) and the after value 1.47 (±0.69). According to calculations, the before C/U ratio value was 1 (±0.26) and the after value was 1.17 ( ±0.29), which showed a statistically significant increase (P < 0.001) [Figure 1]. The power of the test to compare before and after PI-umbilical values was calculated as 61.6% and 33.3% for RI-MCA.

DISCUSSION

This study investigated the effect of administration of MgSO₄ in severe preeclampsia cases on fetal umbilical and MCA blood flow. Based on the results of this study, the injection of MgSO₄ could significantly decrease the RI-umbilical, PI-MCA, and increase C/U ratio.

Fetal distress caused by hypoxia is one of the effects of preeclampsia on the fetus. Probably, circulation disorder is the most important cause of hypoxia and distress.[26] Inadequate placental perfusion can cause fetal reduction of oxygen supply, and thus lead to fetal distress.[21 27]

Several studies have shown the medical effects of MgSO₄ in treating patients with preeclampsia and eclampsia.[28 29] Souza et al,[30 31] assessed fetal MCA and umbilical artery Doppler parameters and measured these parameters 20 min after injection of MgSO₄. They showed that umbilical and MCA RI and PI values are significantly reduced. While in our study these parameters showed no significant change.

In addition, another study showed the reduction of PI in the fetal umbilical artery and MCA due to the injection of MgSO₄.[30] In Dasgupta's study, when compared with control group, the umbilical artery PI value decreased, but the fetal MCA-PI did not change significantly.[32] In another study, the MCA did not change.[33] The impaired perfusion in fetal MCA can be associated with hypoxia and fetal complications.[24 34]

In our study, after injection of MgSO₄, C/U ratio had a significant increase, which shows that the fetal blood supply had improved. Various studies confirmed the efficacy of Doppler ultrasound examination for assessing the vascular status of the fetus and have introduced the C/U ratio as a parameter in assessing fetal blood supply.[35] The C/U ratio shows both inadequate fetal circulation and changes and adaptations in the artery.[17] Hence, this drug (MgSO₄) can cause vasodilatation in the fetal umbilical artery.[36] Some studies did not show the same result.[30 31] The fetal MCA resistance increases in normal pregnancy slightly[21] and the increase is more substantial in preeclampsia and eclampsia. The administration of MgSO₄, therefore, can have beneficial effects on the fetus and can increase perfusion. C/U ratio is a good indicator for assessing the growth and prognosis of the fetus, while the fetal MCA alone does not have the same value.[37 38]

This study also had certain limitations. One of the limitations of this study was the lack of a control group. However, due to the special status of patients with severe preeclampsia, there are inevitable limitations in the design of this study and similar studies. The small sample size was another limitation, which reduced the test power of PI-umbilical and RI-MCA to less than 80%. The lack of significant statistical differences in these two indicators might result from the small sample size of patients. Results of our study and studies of others indicate more extensive studies with larger patient numbers are required to be conducted and if possible a meta-analysis of the results of all existing studies to confirm conclusions about the effects of MgSO₄ on fetal blood flow is also essential.

CONCLUSIONS

Infusion of MgSO₄ significantly decreases the fetal RI-umbilical and PI-MCA and increases C/U ratio indices obtained with color Doppler ultrasound evaluations.

ACKNOWLEDGEMENT

The authors sincerely thank the Head of Research in Kermanshah University of Medical Sciences, who approved and funded the study. This article is extracted from the thesis compiled by Dr. Saeed Mohammadi.

REFERENCES

Hypertension in pregnancy. In: ACOG Technical Bulletin No. 219. Washington, DC: ACOG; 1996.
[Google Scholar]
Organization WH, . Geographic variation in the incidence of hypertension in pregnancy. WHO International collaborative study of hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:80-3.
[Google Scholar]
Roberts JM, Lain KY, . Recent insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23:359-372.
[Google Scholar]
Sibai B, Dekker G, Kupferminc M, . Pre-eclampsia. Lancet. 2005;365:785-99.
[Google Scholar]
Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, . Outcomes of severe pre-eclampsia/eclampsia in yorkshire 1999/2003. BJOG. 2005;112:875-80.
[Google Scholar]
Euser AG, Cipolla MJ, . Magnesium sulfate for the treatment of eclampsia: A brief review. Stroke. 2009;40:1169-75.
[Google Scholar]
Witlin AG, Sibai BM, . Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol. 1998;92:883-9.
[Google Scholar]
Euser AG, Bullinger L, Cipolla MJ, . Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol. 2008;93:254-61.
[Google Scholar]
Hatab MR, Zeeman GG, Twickler DM, . The effect of magnesium sulfate on large cerebral artery blood flow in preeclampsia. J Matern Fetal Neonatal Med. 2005;17:187-92.
[Google Scholar]
Sherman R, Armory P, Moody P, Hope T, Mahajan RP, . Effects of magnesium sulphate on cerebral haemodynamics in healthy volunteers: A transcranial Doppler study. Br J Anaesth. 2003;91:273-5.
[Google Scholar]
Idama TO, Lindow SW, . Magnesium sulphate: A review of clinical pharmacology applied to obstetrics. Br J Obstet Gynaecol. 1998;105:260-8.
[Google Scholar]
Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, . Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate. The Magpie Trial: A randomised placebo-controlled trial? Lancet. 2002;359:1877-90.
[Google Scholar]
Reynolds JD, Chestnut DH, Dexter F, McGrath J, Penning DH, . Magnesium sulfate adversely affects fetal lamb survival and blocks fetal cerebral blood flow response during maternal hemorrhage. Anesth Analg. 1996;83:493-9.
[Google Scholar]
Gramellini D, Folli MC, Raboni S, Vadora E, Merialdi A, . Cerebral-umbilical Doppler ratio as a predictor of adverse perinatal outcome. Obstet Gynecol. 1992;79:416-20.
[Google Scholar]
Bahlmann F, Reinhard I, Krummenauer F, Neubert S, Macchiella D, Wellek S, . Blood flow velocity waveforms of the fetal middle cerebral artery in a normal population: Reference values from 18 weeks to 42 weeks of gestation. J Perinat Med. 2002;30:490-501.
[Google Scholar]
Tarzamni MK, Nezami N, Gatreh-Samani F, Vahedinia S, Tarzamni M, . Doppler waveform indices of fetal middle cerebral artery in normal 20 to 40 weeks pregnancies. Arch Iran Med. 2009;12:29-34.
[Google Scholar]
Ebrashy A, Azmy O, Ibrahim M, Waly M, Edris A, . Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: Case-control study. Croat Med J. 2005;46:821-5.
[Google Scholar]
Yalti S, Oral O, Gurbuz B, Ozden S, Atar F, . Ratio of middle cerebral to umbilical artery blood velocity in preeclamptic and hypertensive women in the prediction of poor perinatal outcome. Indian J Med Res. 2004;120:44-50.
[Google Scholar]
Rana MJ, Amanullah A, Farooq O, . The role of umblical artery doppler in detection and management of fetal growth retardation. Biomedica. 2005;21:4-7.
[Google Scholar]
Kassanos D, Siristatidis C, Vitoratos N, Salamalekis E, Creatsas G, . The clinical significance of Doppler findings in fetal middle cerebral artery during labor. Eur J Obstet Gynecol Reprod Biol. 2003;109:45-50.
[Google Scholar]
Mihu D, Diculescu D, Costin N, Mihu CM, Blaga L, Ciortea R, . Applications of Doppler ultrasound during labor. Med Ultrason. 2011;13:141-9.
[Google Scholar]
Baschat AA, Gembruch U, . The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol. 2003;21:124-7.
[Google Scholar]
Divon MY, . Umbilical artery Doppler velocimetry: Clinical utility in high-risk pregnancies. Am J Obstet Gynecol. 1996;174:10-4.
[Google Scholar]
Vyas S, Nicolaides KH, Bower S, Campbell S, . Middle cerebral artery flow velocity waveforms in fetal hypoxaemia. Br J Obstet Gynaecol. 1990;97:797-803.
[Google Scholar]
Keeley MM, Wade RV, Laurent SL, Hamann VD, . Alterations in maternal-fetal Doppler flow velocity waveforms in preterm labor patients undergoing magnesium sulfate tocolysis. Obstet Gynecol. 1993;81:191-4.
[Google Scholar]
Cunningham FG, Lindheimer MD, . Hypertension in pregnancy. N Engl J Med. 1992;326:927-32.
[Google Scholar]
Dubiel M, Gudmundsson S, Gunnarsson G, Marsal K, . Middle cerebral artery velocimetry as a predictor of hypoxemia in fetuses with increased resistance to blood flow in the umbilical artery. Early Hum Dev. 1997;47:177-84.
[Google Scholar]
Moslemizadeh N, Yousefnejad K, Moghadam TG, Peyvandi S, . Urinary protein assessment in preeclampsia: Which sample is more suitable? 2008112584-8.
[Google Scholar]
Girard B, Beucher G, Muris C, Simonet T, Dreyfus M, . Magnesium sulphate and severe preeclampsia: Its use in current practice. J Gynecol Obstet Biol Reprod (Paris). 2005;34:17-22.
[Google Scholar]
Souza AS, Amorim MM, Coelho IC, Lima MM, Noronha Neto C, Figueroa JN, . Doppler of the umbilical and fetal middle cerebral arteries after magnesium sulfate in preeclampsia. Rev Assoc Med Bras. 2008;54:232-7.
[Google Scholar]
Souza AS, Amorim MM, Coutinho IC, Lima MM, Noronha Neto C, Figueroa JN, . Effect of the loading dose of magnesium sulfate (MgSO4) on the parameters of Doppler flow velocity in the uterine, umbilical and middle cerebral arteries in severe preeclampsia. Hypertens Pregnancy. 2010;29:123-34.
[Google Scholar]
Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D, . Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at >/=34 weeks gestational age. J Obstet Gynaecol Res. 2012;38:763-71.
[Google Scholar]
Twickler DM, McIntire DD, Alexander JM, Leveno KJ, . Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: A randomized controlled trial. Obstet Gynecol. 2010;115:21-5.
[Google Scholar]
Katayama M, Yamamuro A, Ueda Y, Tamita K, Yamabe K, Ibuki M, . Coronary flow velocity pattern assessed noninvasively by transthoracic color Doppler echocardiography serves as a predictor of adverse cardiac events and left ventricular remodeling in patients with acute myocardial infarction. J Am Soc Echocardiogr. 2006;19:335-40.
[Google Scholar]
Makhseed M, Jirous J, Ahmed MA, Viswanathan DL, . Middle cerebral artery to umbilical artery resistance index ratio in the prediction of neonatal outcome. Int J Gynaecol Obstet. 2000;71:119-25.
[Google Scholar]
Poranen AK, Nurmi H, Malminiemi K, Ekblad U, . Vasoactive effects and placental transfer of nifedipine, celiprolol, and magnesium sulfate in the placenta perfused in vitro. Hypertension in Pregnancy. 1998;17:93-102.
[Google Scholar]
Nanthakomon T, Somprasit C, . The value of middle cerebral artery-umbilical artery pulsatility index ratio in prediction of severe fetal growth restriction. Thammasat Medical Journal. 2010;10:264-70.
[Google Scholar]
Ozeren M, Dinc H, Ekmen U, Senekayli C, Aydemir V, . Umbilical and middle cerebral artery Doppler indices in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1999;82:11-6.
[Google Scholar]

INTRODUCTION

MATERIALS AND METHODS

RESULTS

DISCUSSION

CONCLUSIONS

Fulltext Views
3,644

PDF downloads
1,747

View/Download PDF
Download Citations

BibTeX
RIS

Show Sections

[1] Hypertension in pregnancy. In: ACOG Technical Bulletin No. 219. Washington, DC: ACOG; 1996.
[Google Scholar]

[2] Organization WH, . Geographic variation in the incidence of hypertension in pregnancy. WHO International collaborative study of hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:80-3.
[Google Scholar]

[3] Roberts JM, Lain KY, . Recent insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23:359-372.
[Google Scholar]

[4] Sibai B, Dekker G, Kupferminc M, . Pre-eclampsia. Lancet. 2005;365:785-99.
[Google Scholar]

[5] Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, . Outcomes of severe pre-eclampsia/eclampsia in yorkshire 1999/2003. BJOG. 2005;112:875-80.
[Google Scholar]

[6] Euser AG, Cipolla MJ, . Magnesium sulfate for the treatment of eclampsia: A brief review. Stroke. 2009;40:1169-75.
[Google Scholar]

[7] Witlin AG, Sibai BM, . Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol. 1998;92:883-9.
[Google Scholar]

[8] Euser AG, Bullinger L, Cipolla MJ, . Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol. 2008;93:254-61.
[Google Scholar]

[9] Hatab MR, Zeeman GG, Twickler DM, . The effect of magnesium sulfate on large cerebral artery blood flow in preeclampsia. J Matern Fetal Neonatal Med. 2005;17:187-92.
[Google Scholar]

[10] Sherman R, Armory P, Moody P, Hope T, Mahajan RP, . Effects of magnesium sulphate on cerebral haemodynamics in healthy volunteers: A transcranial Doppler study. Br J Anaesth. 2003;91:273-5.
[Google Scholar]

[11] Idama TO, Lindow SW, . Magnesium sulphate: A review of clinical pharmacology applied to obstetrics. Br J Obstet Gynaecol. 1998;105:260-8.
[Google Scholar]

[12] Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, . Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate. The Magpie Trial: A randomised placebo-controlled trial? Lancet. 2002;359:1877-90.
[Google Scholar]

[13] Reynolds JD, Chestnut DH, Dexter F, McGrath J, Penning DH, . Magnesium sulfate adversely affects fetal lamb survival and blocks fetal cerebral blood flow response during maternal hemorrhage. Anesth Analg. 1996;83:493-9.
[Google Scholar]

[14] Gramellini D, Folli MC, Raboni S, Vadora E, Merialdi A, . Cerebral-umbilical Doppler ratio as a predictor of adverse perinatal outcome. Obstet Gynecol. 1992;79:416-20.
[Google Scholar]

[15] Bahlmann F, Reinhard I, Krummenauer F, Neubert S, Macchiella D, Wellek S, . Blood flow velocity waveforms of the fetal middle cerebral artery in a normal population: Reference values from 18 weeks to 42 weeks of gestation. J Perinat Med. 2002;30:490-501.
[Google Scholar]

[16] Tarzamni MK, Nezami N, Gatreh-Samani F, Vahedinia S, Tarzamni M, . Doppler waveform indices of fetal middle cerebral artery in normal 20 to 40 weeks pregnancies. Arch Iran Med. 2009;12:29-34.
[Google Scholar]

[17] Ebrashy A, Azmy O, Ibrahim M, Waly M, Edris A, . Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: Case-control study. Croat Med J. 2005;46:821-5.
[Google Scholar]

[18] Yalti S, Oral O, Gurbuz B, Ozden S, Atar F, . Ratio of middle cerebral to umbilical artery blood velocity in preeclamptic and hypertensive women in the prediction of poor perinatal outcome. Indian J Med Res. 2004;120:44-50.
[Google Scholar]

[19] Rana MJ, Amanullah A, Farooq O, . The role of umblical artery doppler in detection and management of fetal growth retardation. Biomedica. 2005;21:4-7.
[Google Scholar]

[20] Kassanos D, Siristatidis C, Vitoratos N, Salamalekis E, Creatsas G, . The clinical significance of Doppler findings in fetal middle cerebral artery during labor. Eur J Obstet Gynecol Reprod Biol. 2003;109:45-50.
[Google Scholar]

[21] Mihu D, Diculescu D, Costin N, Mihu CM, Blaga L, Ciortea R, . Applications of Doppler ultrasound during labor. Med Ultrason. 2011;13:141-9.
[Google Scholar]

[22] Baschat AA, Gembruch U, . The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol. 2003;21:124-7.
[Google Scholar]

[23] Divon MY, . Umbilical artery Doppler velocimetry: Clinical utility in high-risk pregnancies. Am J Obstet Gynecol. 1996;174:10-4.
[Google Scholar]

[24] Vyas S, Nicolaides KH, Bower S, Campbell S, . Middle cerebral artery flow velocity waveforms in fetal hypoxaemia. Br J Obstet Gynaecol. 1990;97:797-803.
[Google Scholar]

[25] Keeley MM, Wade RV, Laurent SL, Hamann VD, . Alterations in maternal-fetal Doppler flow velocity waveforms in preterm labor patients undergoing magnesium sulfate tocolysis. Obstet Gynecol. 1993;81:191-4.
[Google Scholar]

[26] Cunningham FG, Lindheimer MD, . Hypertension in pregnancy. N Engl J Med. 1992;326:927-32.
[Google Scholar]

[27] Dubiel M, Gudmundsson S, Gunnarsson G, Marsal K, . Middle cerebral artery velocimetry as a predictor of hypoxemia in fetuses with increased resistance to blood flow in the umbilical artery. Early Hum Dev. 1997;47:177-84.
[Google Scholar]

[28] Moslemizadeh N, Yousefnejad K, Moghadam TG, Peyvandi S, . Urinary protein assessment in preeclampsia: Which sample is more suitable? 2008112584-8.
[Google Scholar]

[29] Girard B, Beucher G, Muris C, Simonet T, Dreyfus M, . Magnesium sulphate and severe preeclampsia: Its use in current practice. J Gynecol Obstet Biol Reprod (Paris). 2005;34:17-22.
[Google Scholar]

[30] Souza AS, Amorim MM, Coelho IC, Lima MM, Noronha Neto C, Figueroa JN, . Doppler of the umbilical and fetal middle cerebral arteries after magnesium sulfate in preeclampsia. Rev Assoc Med Bras. 2008;54:232-7.
[Google Scholar]

[31] Souza AS, Amorim MM, Coutinho IC, Lima MM, Noronha Neto C, Figueroa JN, . Effect of the loading dose of magnesium sulfate (MgSO4) on the parameters of Doppler flow velocity in the uterine, umbilical and middle cerebral arteries in severe preeclampsia. Hypertens Pregnancy. 2010;29:123-34.
[Google Scholar]

[32] Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D, . Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at >/=34 weeks gestational age. J Obstet Gynaecol Res. 2012;38:763-71.
[Google Scholar]

[33] Twickler DM, McIntire DD, Alexander JM, Leveno KJ, . Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: A randomized controlled trial. Obstet Gynecol. 2010;115:21-5.
[Google Scholar]

[34] Katayama M, Yamamuro A, Ueda Y, Tamita K, Yamabe K, Ibuki M, . Coronary flow velocity pattern assessed noninvasively by transthoracic color Doppler echocardiography serves as a predictor of adverse cardiac events and left ventricular remodeling in patients with acute myocardial infarction. J Am Soc Echocardiogr. 2006;19:335-40.
[Google Scholar]

[35] Makhseed M, Jirous J, Ahmed MA, Viswanathan DL, . Middle cerebral artery to umbilical artery resistance index ratio in the prediction of neonatal outcome. Int J Gynaecol Obstet. 2000;71:119-25.
[Google Scholar]

[36] Poranen AK, Nurmi H, Malminiemi K, Ekblad U, . Vasoactive effects and placental transfer of nifedipine, celiprolol, and magnesium sulfate in the placenta perfused in vitro. Hypertension in Pregnancy. 1998;17:93-102.
[Google Scholar]

[37] Nanthakomon T, Somprasit C, . The value of middle cerebral artery-umbilical artery pulsatility index ratio in prediction of severe fetal growth restriction. Thammasat Medical Journal. 2010;10:264-70.
[Google Scholar]

[38] Ozeren M, Dinc H, Ekmen U, Senekayli C, Aydemir V, . Umbilical and middle cerebral artery Doppler indices in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1999;82:11-6.
[Google Scholar]